ENERZYME INJECTION

Pays: Australie

Langue: anglais

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingrédients actifs:

ADENOSINE TRIPHOSPHATE; URIDINE TRIPHOSPHATE

Disponible depuis:

AUSRICHTER PTY LTD

DCI (Dénomination commune internationale):

uridine triphosphate(2mg/mL)+adenosine phosphate(14mg/mL)

forme pharmaceutique:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

ADENOSINE TRIPHOSPHATE NUCLEOTIDE Active 14.0 mg/ml; URIDINE TRIPHOSPHATE NUCLEOTIDE Active 2.0 mg/ml

Unités en paquet:

20mL

classe:

VM - Veterinary Medicine

Fabriqué par:

AUSRICHTER

Groupe thérapeutique:

CAT | DOG | HORSE | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH

Domaine thérapeutique:

NUTRITION & METABOLISM

indications thérapeutiques:

MUSCULAR STIMULANT

Descriptif du produit:

Poison schedule: 0; Withholding period: WHP: Meat: Nil; Host/pest details: CAT: [MUSCULAR STIMULANT]; DOG: [MUSCULAR STIMULANT]; HORSE: [MUSCULAR STIMULANT]; Poison schedule: 0; Withholding period: ; Host/pest details: CAT: [MUSCULAR STIMULANT]; DOG: [MUSCULAR STIMULANT]; HORSE: [MUSCULAR STIMULANT]; A muscular stimulant for horses, dogs and cats.

Statut de autorisation:

Registered

Date de l'autorisation:

2023-07-01

Notice patient

INFOPEST VERIFIES THAT THIS LABEL IS CONSISTENT WITH THE NRA
APPROVED TEXT LABEL OF 7/1/97 ________
ENERZYME INJECTION LABEL 29/10/99
PAGE 1/1
Vial label Panel 1, Carton Front and Back Panels
FOR ANIMAL TREATMENT ONLY
ENERZYME
INJECTION
ACTIVE CONSTITUENTS:
2 mg/mL URIDINE TRIPHOSPHATE
14 mg/mL ADENOSINE TRIPHOSPHATE
A MUSCULAR STIMULANT FOR HORSES, DOGS AND CATS
JUROX
20 ML
Vial label Panel 2, Carton Side Panel 1
DIRECTIONS FOR USE:
By intramuscular or subcutaneous injection.
Horses: 4 mL per 100 kg bodyweight.
Dogs and Cats: 1 mL per 10 kg bodyweight.
MEAT WITHHOLDING PERIOD: NIL.
Vial label Panel 3, Carton Side Panel 2
Made in Australia by Jurox Pty Ltd
85 Gardiners Road, Rutherford
NSW 2320 Australia
DISPOSE of container by wrapping with paper and placing in garbage.
STORE below 30
°
C (Room Temperature).
Protect from light.
NRA49461/
B
EXP.
Carton Top Flap
ENERZYME
INJECTION
JUROX
This product is not for sale or use in Victoria.

Résumé des caractéristiques du produit

MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ENERZYME INJECTION
Issue Date: 29JAN08
QAF140
Page 1 of 2
STATEMENT OF HAZARDOUS NATURE
NOT CLASSIFIED AS HAZARDOUS ACCORDING TO CRITERIA OF NOHSC AUSTRALIA
COMPANY DETAILS
Company:
Jurox Pty Limited,
Address:
85 Gardiners Road, Rutherford NSW 2320
Telephone:
[phone] or 1800 023 312
Emergency Telephone No.:
[phone] or 1800 023 312
IDENTIFICATION
Product Name:
Enerzyme Injection
Other Names:
Manufacturer’s Product Code:
50190
UN Number:
None Allocated
Dangerous Goods Class:
None Allocated
Subsidiary Risk:
None Allocated
Hazchem Code:
None Allocated
Poisons Schedule Number:
Not Scheduled
Use:
An injectable stimulant for dogs, cats and horses.
PHYSICAL PROPERTIES / DESCRIPTION
Appearance:
Clear, colourless liquid
Boiling Point/Melting Point:
Vapour Pressure:
Specific Gravity:
1.00 – 1.02
Flashpoint:
Not flammable
Flammability Limits:
Solubility in Water:
Aqueous Solution
OTHER PROPERTIES
INGREDIENTS
CHEMICAL ENTITY
CAS NUMBER
PROPORTION
Adenosine triphosphate
56-65-5
1.4%
Uridine triphosphate
63-39-8
0.2%
Water
to 100%
HEALTH HAZARD INFORMATION
HEALTH EFFECTS
ACUTE
Swallowed:
May cause nausea, vomiting and gastric disturbances.
Eye:
Mild eye irritant
Skin:
Unlikely to present a skin irritancy problem
MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ENERZYME INJECTION
Issue Date: 29JAN08
QAF140
Page 2 of 2
Inhaled:
Unlikely to present an inhalation problem
Injected:
Effects will vary in severity according to the quantity involved, but
will
normally be a localised site reaction (pain, redness, swelling).
CHRONIC:
If poisoning occurs, contact a doctor or Poisons Information Centre,
phone 131126
FIRST AID
_ _
Swallowed:
If more then 15 minutes from a hospital induce vomiting, preferably
using Ipecac Syrup APF.
Eye:
Rinse with large quantities of water for at least 15 minutes. Seek
medical attention.
Skin:
If skin contact occurs, remove contaminated clothing and wash skin
thoroughly
Injected:
Treat as for needlestick injury. Wash area well and disinfect. If
other
symptom